Medical Developments International | MVP - Operating Profit

Stock Price
0.42
Daily Change
-0.01 -2.33%
Monthly
12.00%
Yearly
-26.96%
Q2 Forecast
0.42

Medical Developments International reported AUD-36K in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Genetic Signatures AUD -6.34M 1.67M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organon & Co USD 217M 171M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025